Randomized, Double-Blind, Placebo-Controlled Trial of Nimodipine for the Neurological Manifestations of HIV-1

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

Not specified

Study Completion Date

June 30, 1994

Conditions
AIDS Dementia ComplexHIV Infections
Interventions
DRUG

Nimodipine

DRUG

Zidovudine

Trial Locations (12)

14642

Univ. of Rochester ACTG CRS, Rochester

27599

Unc Aids Crs, Chapel Hill

44106

Case CRS, Cleveland

46202

Indiana Univ. School of Medicine, Infectious Disease Research Clinic, Indianapolis

55455

University of Minnesota, ACTU, Minneapolis

60611

Northwestern University CRS, Chicago

90095

UCLA CARE Center CRS, Los Angeles

02114

Massachusetts General Hospital ACTG CRS, Boston

02118

Bmc Actg Crs, Boston

02215

Beth Israel Deaconess - East Campus A0102 CRS, Boston

Unknown

Washington U CRS, St Louis

University of Washington AIDS CRS, Seattle

Sponsors

Collaborators (2)

All Listed Sponsors
collaborator

Miles

INDUSTRY

collaborator

Glaxo Wellcome

INDUSTRY

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH